NEI Research News

Researchers have found that the three-year progression of myopia (nearsightedness) in a large group of ethnically diverse children who wore progressive addition lenses (PALs or no-line bifocals) was slightly less than that of children who wore single...

Researchers have found that immediately treating people who have early stage glaucoma can delay progression of the disease.

Researchers have discovered that eye drops used to treat elevated pressure inside the eye can be effective in delaying the onset of glaucoma.

More Americans than ever are facing the threat of blindness from age-related eye disease, a new report says. Over one million Americans aged 40 and over are currently blind and an additional 2.4 million are visually impaired.

Atropine eye drops given once a day to treat amblyopia, or lazy eye, the most common cause of visual impairment in children, work as well as the standard treatment of patching one eye.

Researchers report that the overall prevalence of glaucoma in Mexican-Americans is between reported rates for Blacks and Whites.

Glaucoma is one of the most common causes of visual loss in the United States and affects about three million Americans. A standard medical treatment for newly diagnosed glaucoma is using eye drops and/or laser treatment to lower the pressure inside...

High levels of antioxidants and zinc significantly reduce the risk of advanced age-related macular degeneration (AMD) and its associated vision loss.

Researchers have found that the survival rates for two alternative treatments for primary eye cancer–radiation therapy and removal of the eye–are about the same.

A research study of the Mexican-American population over age 40 found that the rate of diabetes in this group is 20 percent–almost twice that of non-Hispanic Whites–and that 15 percent of those with diabetes did not know that they had the disease...